- The perfect storm: Can disaster reduction occur in the face of climate change and population growth?
- Voicing Slavery: Elizabeth Barrett Browning and Mary Prince
- Osteoporosis: Bouncing babies to crumbling wrinklies - the need to own our bones
- What has the King’s Speech done to improve public awareness about stuttering?
- Photons, spacecraft, atomic clocks and Einstein – fundamental physics in the space environment
- London: the divorce capital of the world. ‘Big money’ divorce cases: fairness, gender and judicial discretion
- When technology design provokes errors
- Prometheus and I: building new body parts from stem cells
- Against nature? Homosexuality and evolution
- Child development in developing countries
- Did Democracy Cause the American Civil War?
- The highs and lows of our nearest star, the Sun
- From pathogen to ally: engineering viruses to treat disease
- Designing for students
- The price of the pouch: the evolutionary ramifications of mammalian reproductive strategies
Download Lunch Hour Lectures
to your mobile device
from 7 days after the live event
at iTunes U.
From pathogen to ally: engineering viruses to treat disease
12 December 2011
Thursday 1 December 2011
Professor Mary Collins (UCL Immunology)
Recombinant DNA technology has been in widespread use since the 1980s. It has allowed the engineering of viral genomes to produce a number of safe and useful medicines. To mark World AIDS Day, this lecture discusses the development of engineered viruses, such as HIV, to treat rare genetic disorders – “gene therapy”- and the use of these engineered viruses as vaccines.
Page last modified on 12 dec 11 16:17